TC21 promotes cell motility and metastasis by regulating the expression of E-cadherin and N-cadherin in hepatocellular carcinoma

被引:21
作者
Luo, Hairong [1 ,2 ]
Hao, Xiangfang [1 ]
Ge, Chao [1 ]
Zha, Fangyu [3 ]
Zhu, Miaoxin [3 ]
Chen, Taoyang [4 ]
Yao, Ming [3 ]
He, Xianghuo [1 ]
Li, Jinjun [1 ]
机构
[1] Shanghai Jiao Tong Univ, Inst Canc, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes, Shanghai 200032, Peoples R China
[2] Fudan Univ, Shanghai Med Coll, Shanghai 200433, Peoples R China
[3] Shanghai Jiao Tong Univ, Inst Canc, Shanghai Canc Inst, Dept Expt Pathol, Shanghai 200032, Peoples R China
[4] Qi Dong Liver Canc Inst, Qi Dong, Peoples R China
关键词
TC21; E-cadherin; N-cadherin; metastasis; hepatocellular carcinoma; INTESTINAL EPITHELIAL-CELLS; BREAST-CANCER; RAS; TRANSFORMATION; PROTEIN; LINE; TUMORIGENESIS; ACTIVATION; MUTATION; KINASE;
D O I
10.3892/ijo_00000736
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hepatocellular carcinoma (HCC) is an aggressive type of cancer, and it may be at an advanced stage when it is detected. It has been shown that TC21, a member of the Ras superfamily, is associated with the proliferation, migration and transformation of tumor cells. Previous studies have shown that TC21 is overexpressed in breast, esophageal and oral carcinomas, and that it is closely associated with the early stages of tumorigenesis. In this study, we demonstrate that TC21 overexpression promotes the motility of HCC cells in vitro and intrahepatic metastasis in vivo. Furthermore, experiments examining the effects of both the ectopic expression of TC21 and siRNA treatment in HCC cells showed that TC21 alters the expression of the adhesive molecules E-cadherin and N-cadherin. Our data suggest that TC21 is associated with tumor progression and poor prognosis in HCC.
引用
收藏
页码:853 / 859
页数:7
相关论文
共 25 条
[1]   Identification of differentially expressed genes in oral squamous cell carcinoma [J].
Arora, S ;
Matta, A ;
Shukla, NK ;
Deo, SVS ;
Ralhan, R .
MOLECULAR CARCINOGENESIS, 2005, 42 (02) :97-108
[2]   Ras-related TC21 is activated by mutation in a breast cancer cell line, but infrequently in breast carcinomas in vivo [J].
Barker, KT ;
Crompton, MR .
BRITISH JOURNAL OF CANCER, 1998, 78 (03) :296-300
[3]   HUMAN ONCOGENE OF THE RAS SUPERFAMILY UNMASKED BY EXPRESSION CDNA CLONING [J].
CHAN, AML ;
MIKI, T ;
MEYERS, KA ;
AARONSON, SA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (16) :7558-7562
[4]  
Clark GJ, 1996, ONCOGENE, V12, P169
[5]   CHARACTERIZATION OF 4 NOVEL RAS-LIKE GENES EXPRESSED IN A HUMAN TERATOCARCINOMA CELL-LINE [J].
DRIVAS, GT ;
SHIH, A ;
COUTAVAS, E ;
RUSH, MG ;
DEUSTACHIO, P .
MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (04) :1793-1798
[6]   Signaling pathways regulating TC21-induced tumorigenesis [J].
Erdogan, Mete ;
Pozzi, Ambra ;
Bhowmick, Neil ;
Moses, Harold L. ;
Zent, Roy .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (38) :27713-27720
[7]   ABERRANT FUNCTION OF THE RAS-RELATED PROTEIN TC21/R-RAS2 TRIGGERS MALIGNANT TRANSFORMATION [J].
GRAHAM, SM ;
COX, AD ;
DRIVAS, G ;
RUSH, MG ;
DEUSTACHIO, P ;
DER, CJ .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (06) :4108-4115
[8]   TC21 and Ras share indistinguishable transforming and differentiating activities [J].
Graham, SM ;
Oldham, SM ;
Martin, CB ;
Drugan, JK ;
Zohn, IE ;
Campbell, S ;
Der, CJ .
ONCOGENE, 1999, 18 (12) :2107-2116
[9]  
Hajra KM, 2002, CANCER RES, V62, P1613
[10]  
HUANG Y, 1995, ONCOGENE, V11, P1255